N-(3-Aminopropyl)morpholine → HCID 178422596, compound

HRID 884656Notes

Reaction equation

HRID 884656 reaction equation
[OH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]([C:15]3[CH:16]=[C:17]([O:21][CH2:22][C:23](O)=[O:24])[CH:18]=[CH:19][CH:20]=3)[NH:11][C:12](=[O:14])[N:13]=2)=[CH:4][C:3]=1[CH3:26].[O:27]1[CH2:32][CH2:31][N:30]([CH2:33][CH2:34][CH2:35][NH2:36])[CH2:29][CH2:28]1.ON1C2C=CC=CC=2N=N1.CCN=C=NCCC[N+](C)(C)C.[I-]>ClC(Cl)C.CN(C)C=O>[OH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[C:10]([C:15]3[CH:16]=[C:17]([O:21][CH2:22][C:23]([NH:36][CH2:35][CH2:34][CH2:33][N:30]4[CH2:31][CH2:32][O:27][CH2:28][CH2:29]4)=[O:24])[CH:18]=[CH:19][CH:20]=3)[NH:11][C:12](=[O:14])[N:13]=2)=[CH:4][C:3]=1[CH3:26]

Participants

7

Reactant 4

HCID 61055N-(3-Aminopropyl)morpholineHCID 757711-HydroxybenzotriazoleHCID 1222421-(3-(Dimethylamino)propyl)-3-ethylcarbodiimide methiodideHCID 178422597({3-[6-(4-Hydroxy-3-methylphenyl)-2-oxo-2,3-dihydropyrimidin-4-yl]phenyl}oxy)acetic acid2×

Product 1

HCID 178422596HCID 178422596, compoundYield 20.9%

Reagents, catalysts & solvents 2

HCID 6228DimethylformamideSolventHCID 63651,1-DichloroethaneSolvent

Procedure

({3-[6-(4-hydroxy-3-methylphenyl)-2-oxo-2,3-dihydropyrimidin-4-yl]phenyl}-oxy)acetic acid (Compound 222, 17 mg, 48 umol) and 3-morpholinopropan-1-amine (5.8 mg, 40 umol) were dissolved in dichloroethane (1.25 mL) and N,N-dimethylformamide (0.79 mL). To this solution was added 1-hydroxybenzotriazole (6.8 mg, 50 umol) followed by 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide methiodide (17.8 mg, 60 umol). The reaction mixture was stirred at room temperature for 15 hours and was concentrated in vacuo. The reaction mixture was purified by reverse phase HPLC to give 4 mg of product. 1H NMR (400 MHz, d6-DMSO): δ 8.31 (s, 1H), 8.17 (t, 1H), 7.96 (s, 1H), 7.87 (dd, 1H), 7.75 (d, 1H), 7.68 (s, 1H), 7.47 (t, 1H), 7.38 (s, 1H), 7.17 (dd, 1H), 6.92 (d, 1H), 4.61 (s, 2H), 3.61 (t, 4H), 3.21-3.16 (m, 2H), 2.30-2.22 (m, 6H), 2.20 (s, 3H), 1.63-1.57 (m, 2H). MS (EI): 480 (MH+).

Workup

  1. concentrationwas concentrated in vacuo
  2. customThe reaction mixture was purified by reverse phase HPLC

Sources & evidence

ORD record
ord-f2c5b2b6c72548798a9f2991c1427a0a
Source dataset
uspto-grants-2012_08
Patent number
US08242129B2

Reaction notes

Loading…